Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations : a pooled analysis from four clinical trials
-
Allan, John N. (Weill Cornell Medicine)
;
Shanafelt, Tait (Stanford University Medical Center) ;
Wiestner, Adrian (National Heart, Lung, and Blood Institute) ;
Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ;
O'Brien, Susan M. (University of California Irvine) ;
Li, Jianling (Pharmacyclics LLC) ;
Krigsfeld, Gabriel (Pharmacyclics LLC) ;
Dean, James P. (Pharmacyclics LLC) ;
Ahn, Inhye E. (National Heart, Lung, and Blood Institute) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
